Product Discontinuation Notice

Dear Customer,

after careful consideration, QIAGEN has decided to discontinue the production of the aLF Reader with May 30, 2021 as final date of order placement and June 30, 2021 as final date of delivery. We will continue to provide lifecycle and service support until June 30, 2026.

While we regret any inconvenience this announcement may cause, we are pleased to supply you with alternate reader solutions for rapid testing from our subsidiary company DIALUNOX GmbH. Feel free to contact us for further questions.

aLF Reader – New Tests Available

We are very happy to announce that there are new tests available for our aLF Reader. Our Partner, Coris BioConcept shortly has launched two new tests in the area of infectious diseases. The first of these tests, Clostridium K-SeT, allows the specific detection of C. difficile’s GDH (Glutamate Dehydrogenase) in stool specimen. The second test has been developed to proof Helicobacter pylori. Moreover Coris BioConcept did also launch new tests in the area of Antibiotic resistance to track Carbapenemase-resistant Enterobacteriaceae which represent a major public health concern worldwide due to their broad spectrum of resistance. We are very proud to see the content for our aLF Reader growing so fast. Learn more about the new tests: